Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study. (Q52860239)
Jump to navigation
Jump to search
scientific article published on 8 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study. |
scientific article published on 8 July 2016 |
Statements
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study (English)
Silvana Canevari
Massimo Di Maio
Francesco Raspagliesi
Maria Luisa Carcangiu
Roberto Sorio
Gennaro Chiappetta
Gian Franco Zannoni
Antonella Savarese
Mariantonia Carosi
Paolo Scollo
Enrico Breda
Viviana Murgia
Multicentre Italian Trials in Ovarian cancer (MITO) translational group
Daniela Russo
Sandro Pignata